Regina Paolillo - 01 Jul 2022 Form 4 Insider Report for TTEC Holdings, Inc. (TTEC)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
06 Jul 2022, 16:42:10 UTC
Prior SEC filing
05 Jul 2022
Next SEC filing
04 Oct 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Margaret B. McLean as Attorney-in-Fact for Regina M. Paolillo

Key filing fact

Regina Paolillo filed Form 4 for TTEC Holdings, Inc. (TTEC) on 06 Jul 2022.

Key facts

  • This page summarizes Regina Paolillo's Form 4 filing for TTEC Holdings, Inc. (TTEC).
  • 7 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 06 Jul 2022, 16:42.

Change

  • Previous filing in this sequence was filed on 05 Jul 2022.
  • Current net transaction value: -$196,222.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TTEC transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+4,715
Change %
+2.1%
Price
$0.000000
Shares after
230,190
Date
01 Jul 2022
Ownership
Direct
Footnotes
F1
TTEC transaction

Common Stock

Tax liability

Transaction value
$141,133
Shares
-2,070
Change %
-0.9%
Price
$68.18
Shares after
228,120
Date
01 Jul 2022
Ownership
Direct
Footnotes
F2
TTEC transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+1,840
Change %
+0.81%
Price
$0.000000
Shares after
229,960
Date
01 Jul 2022
Ownership
Direct
Footnotes
F3
TTEC transaction

Common Stock

Tax liability

Transaction value
$55,089
Shares
-808
Change %
-0.35%
Price
$68.18
Shares after
229,152
Date
01 Jul 2022
Ownership
Direct
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TTEC transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-4,715
Change %
-33%
Price
$0.000000
Shares after
9,429
Date
01 Jul 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,715
Exercise price
$0.000000
Footnotes
F1
TTEC transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-1,840
Change %
-25%
Price
$0.000000
Shares after
5,520
Date
01 Jul 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,840
Exercise price
$0.000000
Footnotes
F3
TTEC transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+8,654
Change %
Price
$0.000000
Shares after
8,654
Date
01 Jul 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
8,654
Exercise price
$0.000000
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Reflects vesting of Restricted Stock Units ("RSUs") on July 1, 2022. The Reporting Person initially received 18,858 time-based RSUs on July 1, 2020. The RSUs vest in four installments of 25% per year beginning on July 1, 2021.

Footnote F2

Reflects withholding of shares to satisfy tax obligations in connection with the vesting of RSUs. No shares were sold.

Footnote F3

Reflects vesting of RSUs on July 1, 2022. The Reporting Person initially received 7,360 time-based RSUs on July 1, 2021. The RSUs vest in four installments of 25% per year beginning on July 1, 2022.

Footnote F4

The Reporting Person received 8,654 time-based RSUs on July 1, 2022. The RSUs vest in four installments of 25% per year beginning on July 1, 2023.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .